Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Fine-scale exogenous attention within the foveola selectively enhances contrast gain at low-to-mid spatial frequencies while increasing response gain across a broad spatial frequency range.
You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...
Detailed price information for Creative Medical Technology Holdings Inc (CELZ-Q) from The Globe and Mail including charting and trades.
Cohere Technologies Wins $28 Million U.S. Government Contract to Develop Multi-Waveform RAN for ISAC
Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...
After being left unprotected in Phase 1, Julia Gosling rejected an FPO in Phase 2 to remain a part of the Seattle Torrent's core. Troy Parla / Getty Images The third phase of the PWHL’s multi-step ...
FutureG Office is investing in cutting-edge, next-gen techIt has handed $28m in funding to Cohere Technologies for the ...
Menstrual cycle phases influence heart autonomic regulation, showing HRV variations, yet muscle performance and mood states ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...
Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results